Jang Oh - Aminologics CoLtd Co-Chief Executive Officer, Director
| 074430 Stock | KRW 1,503 8.00 0.54% |
CEO
Jang Oh is Co-Chief Executive Officer, Director of Aminologics CoLtd since 2014.
| Age | 60 |
| Tenure | 10 years |
| Phone | (82) 2 761 4573 |
| Web | www.aminologics.co.kr |
Aminologics CoLtd Management Efficiency
The company has return on total asset (ROA) of 0.0325 % which means that it generated a profit of $0.0325 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 9.1136 %, meaning that it generated $9.1136 on every $100 dollars invested by stockholders. Aminologics CoLtd's management efficiency ratios could be used to measure how well Aminologics CoLtd manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 6 records | CEO Age | ||
| Hyeon Park | Sungho Electronics Corp | 59 | |
| Yeong Shin | DAEDUCK ELECTRONICS CoLtd | N/A | |
| Hwan Park | Sungho Electronics Corp | 57 | |
| Man Kang | Vissem Electronics Co | 63 | |
| Mu Yim | Daejoo Electronic Materials | 70 | |
| Jong Lee | ABCO Electronics Co | 58 | |
Management Performance
| Return On Equity | 9.11 | |||
| Return On Asset | 0.0325 |
Aminologics CoLtd Leadership Team
Elected by the shareholders, the Aminologics CoLtd's board of directors comprises two types of representatives: Aminologics CoLtd inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aminologics. The board's role is to monitor Aminologics CoLtd's management team and ensure that shareholders' interests are well served. Aminologics CoLtd's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aminologics CoLtd's outside directors are responsible for providing unbiased perspectives on the board's policies.
| HunYeol Yun, Chief Officer | ||
| Gwang Park, Director | ||
| Jang Oh, Co-Chief Executive Officer, Director | ||
| KyungII Kim, President | ||
| JaeGwan Lee, Managing Director | ||
| Seong Oh, Co-Chief Executive Officer, Director | ||
| WonSup Kim, Managing Division | ||
| Seong Park, Director | ||
| Yeon Kim, Director |
Aminologics Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aminologics CoLtd a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 9.11 | |||
| Return On Asset | 0.0325 | |||
| Profit Margin | 0.36 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 238.08 B | |||
| Shares Outstanding | 94.06 M | |||
| Shares Owned By Insiders | 31.26 % | |||
| Shares Owned By Institutions | 0.51 % | |||
| Price To Sales | 8.45 X | |||
| Revenue | 22.85 B |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aminologics CoLtd. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Aminologics CoLtd information on this page should be used as a complementary analysis to other Aminologics CoLtd's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for Aminologics Stock analysis
When running Aminologics CoLtd's price analysis, check to measure Aminologics CoLtd's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aminologics CoLtd is operating at the current time. Most of Aminologics CoLtd's value examination focuses on studying past and present price action to predict the probability of Aminologics CoLtd's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aminologics CoLtd's price. Additionally, you may evaluate how the addition of Aminologics CoLtd to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |